HCC cell metabolism exhibits high utilization of aerobic glycolysis compared with non-cancerous cells (Feng et al., 2020), and altered HCC metabolism may be due, at least in part to the inhibition of PDC. The gene discussed is PDC; the disease is hepatocellular carcinoma.